Otonomy Announces Multiple Presentations at Association for Research in Otolaryngology Annual Meeting

Back to Jobs

SAN DIEGO , Feb. 06, 2019 (GLOBE NEWSWIRE) — Otonomy , Inc. (NASDAQ: OTIC), a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, today announced multiple presentations at the upcoming Association for Research in Otolaryngology (ARO) 42nd Annual

Apply Now